ResMed | RMD - SCHULD

Aktienkurs
233.63
Täglich Wechseln
3.02 1.31%
Monatlich
-9.76%
Jährlich
6.07%
Q1 Prognose
223.87




SCHULD Veränderung Datum
Ansell USD 805.6M 51.6M 2025-06
Artivion USD 317.78M 619K 2024-12
AtriCure USD 76.73M 521K 2025-09
Baxter International USD 9.71B 13M 2025-09
Cochlear AUD 235.7M 10.9M 2025-06
Cooper Companies USD 2.51B 27M 2025-09
CSL USD 11.96B 219M 2024-12
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Globus Medical USD 119.34M 1.76M 2025-09
Haemonetics USD 1.22B 54K 2025-09
Hologic USD 2.63B 104.3M 2025-09
Idexx Laboratories USD 1.11B 124.31M 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
Masimo USD 586.2M 56M 2025-09
Medtronic USD 29.1B 491M 2025-09
Philips EUR 8.38B 41M 2025-09
Ramsay Health Care AUD 12.12B 864.4M 2025-06
ResMed USD 846.35M 178.06M 2025-09
Sigma Healthcare AUD 137.64M 1.01M 2024-07
Sonic Healthcare AUD 4.8B 282.9M 2024-12
Steris USD 2.06B 10.4M 2025-09
Teleflex USD 2.77B 774M 2025-09
Thermo Fisher Scientific USD 35.68B 451M 2025-09